Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00720694 · ClinicalTrials.gov registry record · Phase 3
Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome
A Phase 3 study of Plantar Fasciitis, sponsored by Storz Medical.
- Completed
- Registry status
- Phase 3
- Development phase
- 250
- Enrollment target
- 6
- Study locations
NCT00720694: Completed Phase 3 study of Plantar Fasciitis, sponsored by Storz Medical.
NCT00720694 is a Phase 3 study of Plantar Fasciitis that has completed, run by Storz Medical. The registered enrollment target is 250 participants, above the 67-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (273% higher). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00720694, a Phase 3 study of Plantar Fasciitis, has completed, sponsored by Storz Medical.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 250 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to determine if the Storz Duolith SD1 is more effective than placebo for treatment of heel pain syndrome for patients who have failed conservative treatment with other therapies.
Primary Outcome
Sum of three VAS scales
Conditions Studied
Interventions
- DEVICE Duolith SD1
- DEVICE Sham Duolith SD1
Study Locations (6)
Connecticut
- Connecticut Orthopedics Specialists - Hamden
- Advanced Footcare Specialists of Connecticut, LLC - Newtown
California
- Palo Alto Medical Fondation - Palo Alto
New York
- Galli Podiatric Foot and Ankle Associates - New York
Ohio
- Ankle and Foot Care Centers - Boardman
Washington
- The Sports Medicine Clinic - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2006-06 |
| Phase | Phase 3 |
What the finished NCT00720694 record still lists
NCT00720694 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, above the 67-participant average among 6 other Plantar Fasciitis trials with a reported enrollment target (273% higher).
The record links to 1 condition, with Plantar Fasciitis appearing as the primary indexed condition, and to 2 interventions - of which Duolith SD1 is the first listed.
NCT00720694 lists 6 locations in 5 states (Connecticut, California, New York).
Frequently Asked Questions
What is clinical trial NCT00720694 about?
NCT00720694 is a clinical study titled "Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome". The purpose of this study is to determine if the Storz Duolith SD1 is more effective than placebo for treatment of heel pain syndrome for patients who have failed conservative treatment with other therapies.
What is the current status of trial NCT00720694?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 250 participants. The study started on 2006-06.
What conditions does trial NCT00720694 study?
This clinical trial studies the following conditions: Plantar Fasciitis.
What interventions are being tested in trial NCT00720694?
The interventions under investigation include: Duolith SD1 (DEVICE), Sham Duolith SD1 (DEVICE).
Who is sponsoring clinical trial NCT00720694?
This trial is sponsored by Storz Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00720694 being conducted?
This trial has 6 study locations across California, Connecticut, New York, Ohio, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Plantar Fasciitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lateral Plantar Artery Embolization For Plantar Fasciitis
RECRUITING · Phase 1
-
The Effects of Terrain Variation on Intrinsic Foot Musculature in Healthy Individuals and Individuals With Plantar Fasciitis
RECRUITING · NA
-
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
COMPLETED · Phase 2
-
Treatment of Plantar Fasciitis With Dorsiflexion Night Splints and Medial Arch Supports
COMPLETED · Phase 4
-
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
COMPLETED · Phase 2
-
Comparative Study of Amniotic Membrane Injectable in the Treatment of Recalcitrant Plantar Fasciitis
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia